davita deliv strong fourth quarter boost ep
page full analyst note feb
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim jan
price data feb
rate updat feb
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
sell medic group focus
almost exclus provid servic end-stag renal
diseas esrd patient unit state expand
built largest network dialysi clinic
de novo expans acquisit expect continu
grow similar fashion global benefit on-going growth
esrd patient popul although new regulatori initi
 may alter firm strategi slightli
specif trump administr aim expand
home-bas treatment transplant esrd patient
one top esrd caregiv countri aim
benefit initi particularli home-bas dialysi
treatment current lead coordin home-bas
dialysi manag claim remain indiffer
whether patient receiv dialysi treatment clinic
home addit suspect clinic would benefit
extend at-hom treatment stage help patient
continu work turn remain profit
commerci insur plan substanti part
month possibl medicar take lead
determin reimburs rate esrd treatment
eventu esrd patient need in-clin therapi unless
receiv kidney transplant unfortun esrd patient
suppli demand transplant remain greatli mismatch
averag wait list time around four year expect
chang dramat sustain basi despit recent
uptick suppli pervers benefit opioid crisi
wait though esrd patient need receiv dialysi
treatment either home clinic
factor mind manag recent gave multi-year
guidanc revenu billion billion
ep think achiev
especi continu repurchas share healthi
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
largest provid dialysi servic unit state
boast market share eclips measur patient
clinic firm oper facil world-wide end
 treat patient global year
receiv approxim sale govern primarili
medicar reimburs rate remain come
commerci insur howev commerci insur repres
 patient treat repres nearli
profit gener dialysi busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
davita deliv strong fourth quarter boost
narrow-moat turn fourth-quart result
slightli estim compani rais
outlook moder howev even firm
updat guidanc roughli line project
may tweak underli forecast
expect materi chang fair valu estim
quarter turn billion sale
growth year year roughli line capit iq
consensu growth includ normal organ
treatment growth posit
adjust earn per share doubl
quarter well consensu
slightli expect strong ep growth
affect share repurchas administr cost
control appreci repurchas
million share averag price discount
fair valu estim howev share overvalu
opinion hope manag refrain
highlight cash flow bit higher
expect anticip lower-
than-expect averag day sale outstand tax
paid reoccur therefor expect
materi chang free cash flow estim base
perform
near
left line-item outlook
rais ep guidanc
new calcimimet ballot
expect earn estim alreadi
within manag guidanc albeit low end
may adjust project consid
trend expect materi chang fair
valu estim see share slightli overvalu
trim fair valu estim
per share take fresh look
organ valu roughli time
expect earn expect earn per share
growth compound annual next
five year includ recent potenti share repurchas
five year end expect sale
grow compound annual outlook driven
primarili busi grow similar
compound annual rate influenc
expect patient growth intern expect much
robust growth rate given long runway
global dialysi clinic landscap strategi
grow busi specif assum
intern busi grow low doubl digit
compound annual next five year howev
much smaller size intern segment
compar busi constrain effect
intern expans top line
begin becom profit sale
davita medic group optum franchis
help keep profit around
oper margin basi addit firm
repurchas share heavili expect
repurchas next sever year albeit
lower magnitud total expect item boost
earn per share compound annual
next five year basi point higher
discount assumpt weight averag
cost capit around
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
base-cas scenario scenario could occur davita
lose market share develop market increas
at-hom care chang market dynam growth
emerg market develop expect
scenario also assum oper margin
basi point lower base-cas
scenario assumpt ep grow
compound annual next five year
roughli growth account share
view like even dire
scenario bear-cas scenario possibl
exampl medicar scenario elimin
privat insur industri could jeopard
profit even extrem public option scenario could
significantli cut earn power signific
portion commerci busi switch medicar
dug narrow moat dialysi servic oper
clinic unit state believ
compani competit advantag busi
help gener return invest capit includ
goodwil high singl digit averag throughout
explicit forecast period moder
capit cost see intang asset
scale-rel advantag primari moat sourc
term intang asset built largest
network dialysi clinic sever decad
base part brand reput high-qual
servic extens physician relationship conveni
locat
influenc
busi -- referr nephrologist
lifeblood
firm reput qualiti remain especi
import continu deliv high-qual
reimburs pressur could aris
flow given essenti strong posit within
bull-cas scenario valu
time expect earn scenario
next five year basi point higher
base scenario scenario could occur davita
steal market share grow
import region intern busi grow
basi point higher
base-cas scenario assumpt signific
share repurchas ep grow compound
annual next five year
bear-cas scenario valu per share
time expect earn scenario
assum revenu grow compound annual
next five year basi point lower
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
metric essenti nich healthcar servic
center medicar medicaid servic rate
clinic care qualiti patient survey result
easili access potenti user one
may argu smaller clinic could deliv similar servic
qualiti data suggest clinic
tough time replic servic qualiti
freseniu regularli demonstr exampl
top two player nich score better clinic qualiti
franchis averag judg
varieti factor includ hospit mortal rate
bloodstream infect wast remov consist
influenc doctor referr davita
estim referr relationship
practic nephrologist qualiti
rate also influenc penalti impos
under-perform facil freseniu
avoid penalti higher rate clinic
base qualiti servic offer
think aspect relationship refer
nephrologist provid intang asset well
exampl refer physician ownership stake
clinic oper specif
facil quarter clinic
joint ventur arrang believ
arrang give partial owner incent refer patient
specif clinic signific intang
asset opinion also clinic employ medic
director consist nephrologist nephrologist group
refer dialysi clinic receiv compens
provid medic program guidanc
administr function deni
refer physician requir send patient
specif clinic believ natur financi incent
perceiv qualiti base influenc certain clinic
loyalti
recommend help determin patient care
addit widespread clinic locat offer
patient conveni particularli import
consid regularli receiv typic
treatment three four hour per day three time per
week rest live get success
kidney transplant consid gruel schedul
alreadi sick patient addit commut time
treatment facil remain major point concern
physician patient determin
treatment plan therefor take care locat
clinic conveni area serv esrd patient
effici also see mild switch cost relat
conveni locat patient slot
shift high-qual conveni dialysi center
patient would littl incent leav facil
care team although see switch cost
support moat rather primari moat sourc
beyond intang asset think scale-rel
factor lead cost advantag negoti power
key payer help gener econom profit
basic level today dialysi servic industri
embodi third-parti payer incentiv use cheaper
outpati facil dialysi clinic rather acut
care set hospit lower cost treat
typic enjoy much lower overhead cost
hospit peer reimburs payer lower
rate fundament cost advantag
exampl receiv emerg dialysi treatment
acut care hospit would cost mani multipl
schedul outpati treatment would cost around
averag per treatment third-parti
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
payer incent drive esrd patient cheaper
outpati altern care regular basi
addit think top-tier dialysi servic provid
enjoy scale-rel advantag rel healthcar
servic even dialysi clinic peer
freseniu oper similar scale cumul treat
outpati dialysi patient
scale-rel advantag contribut price power
commerci insur think
negoti posit substanti differ
freseniu given similar market posit think
player enjoy stronger negoti posit
health insur differenti especi import
dialysi servic sinc nearli industri profit
deriv commerci
insur dialysi
industri concentr appear much stronger
major healthcar system exampl top
hospit claim hospit market
top independ refer lab narrow-moat
labcorp quest cumul claim less
lab servic market scale differ appear give
freseniu much stronger negoti posit
rel commerci insur averag
caregiv exampl averag dialysi treatment
commerci insur pay time
govern would pay dialysi treatment
differenti substanti higher averag
healthcar servic provid garner commerci
insur versu medicar roughli time
gener econom return opinion
commerci payer negoti perspect view
dialysi industri stronger narrow moat refer
lab industri much stronger hospit space
gener view no-moat industri
except narrow-moat
rel dialysi clinic see scale-rel cost
advantag freseniu medicar
payment advisori commiss medpac identifi
higher volum dialysi facil cost-per-treat
advantag base direct report individu clinic
base treatment per facil think
freseniu benefit mild cost advantag
smaller dialysi clinic peer think cost
advantag influenc intern effici probabl
relat experi standard
oper exampl averag freseniu
clinic oper higher potenti capac
higher util fewer full-tim employe
smaller peer addit believ
freseniu negoti leverag major
treatment input includ pharmaceut suppli
smaller clinic spread gener
administr cost larger base clinic
smaller clinic well factor help reduc
overal cost per treatment top-tier player rel
smaller-scal peer help top-tier player
moat trend appear stabl us compani
oper oligopolist dialysi servic market
would difficult new competitor enter
destabil oper largest network clinic
 conveni locat relationship
local physician continu make
attract choic patient also suspect firm
scale-rel advantag especi relat commerci
insur make profit remain
intact long haul note though home-rel
option becom viabl choic end user
patient receiv treatment
home world today aim particip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
remain significantli oppos plan next
year view scenario privat insur provid
medic pharmaceut benefit employ
even govern program much like
extrem medicar scenario privat
insur industri longer exist poll show
ad public option current healthcar system
support two third potenti voter
support even republican reflect
view well like scenario suspect
abl keep gener solid profit
 dialysi servic busi import
econom profit
grow at-hom trend goal get
patient at-hom treatment state
previous remain indiffer locat
treatment believ at-hom patient
remain affili reimburs clinic
patient still train monitor
regularli despit at-hom treatment statu
recogn one firm intang asset
conveni locat may becom less import
long run see trend significantli influenc
return five-year forecast period would also
note continuum care at-hom
patient eventu treat clinic ultim
make clinic relationship import end user
overal see gener stabl dynam moat
sourc dialysi servic
despit gener stabl trend continu
monitor polici landscap signific chang
importantli think medicar requir
elimin privat insur industri would
repres neg catalyst industri
enact without signific medicar rate chang
dialysi current depend commerci
insur patient virtual profit oper
near break-even level medicar patient
intern oper modestli profit
compani patient convert
adjust believ compani return would drop
capit cost fortun poll suggest
half popul support medicar
scenario believ scenario repres
low-prob less risk within forecast
period would requir signific shift current
democrat major senat new presid
left wing democrat parti republican voter
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oth esrd patient popul continu grow
healthi rate around globe
posit
enjoy top-tier statu essenti dialysi
busi expect competit dynam
neg affect attract posit anytim
owhil grow at-hom care could chang
busi model bit could also benefit
esrd patient abl continu work
stay commerci insur plan
opubl requir like medicar option
like medicar want could reduc
industri profit insur coverag shift away
employer-bas plan
medicar
reimburs rate chang significantli
fix oblig could weigh stock
especi profit declin
ostat govern california push
back charit assist program allow
patient benefit employer-bas insur
longer cut profit potenti
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
signific leverag especi consid
leas oblig recapit balanc sheet
repurchas share follow sale davita
medic group owe billion debt held
billion cash invest septemb
within net leverag rang time oper
leas oblig billion add anoth turn roughli
leverag refinanc mani oblig
matur schedul appear easili manag though
less million come due annual
compar annual free cash flow oper cash flow
minu capit expenditur around billion annual
period beyond though suspect davita
seek refin oblig come due
billion debt matur
compani continu repurchas share well
drain excess cash flow
billion repurchas first three quarter
board author anoth billion repurchas
author expir date expect davita
continu repurchas share make acquisit
 intern dialysi clinic excess cash flow
financ proce
reimburs pressur could aris
flow given essenti servic strong posit
 dialysi industri biggest risk surround on-going
medicar debat current depend
commerci insur patient virtual profit
oper near break-even level medicar patient
substanti part compani
commerci patient convert medicare-level
substanti lose busi medicar
profit would
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
requir elimin privat insur industri
would need enact view low
probabl albeit high risk scenario explicit
forecast period see public option much like
 healthcar system time frame
signific uncertainti surround would
affect employer-bas insur plan statu quo
increas access probabl like scenario
also see uncertainti around effort treat esrd
patient home posit need dialysi clinic
evapor scenario sinc at-hom patient need
train monitor even receiv
treatment clinic howev recogn one
firm major intang asset conveni locat
may becom less import could influenc return
long term technolog threat regen
medicin mechan devic elimin need
dialysi could emerg disrupt busi model
although see threat unlik
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
share
fund
share
fund
give standard mark capit stewardship
although think score weakli categori
neg purchas healthcar partner
cut firm return invest capit
includ goodwil extend period time prior
transact estim roic stood
low doubl digit directli deal roic declin
basi point subsequ problem
includ goodwil intang impair cut even
roic overal expect get
back predeal roic even outer year explicit
forecast fortun firm top-tier posit
dialysi servic market strong roic
remain wacc sinc acquisit
estim stay wacc next year
manag team decis stray core
compet dialysi servic appear narrow
firm moat bit opinion opposit
expect manag team deliv
futur would skeptic firm stray far
chronic kidney diseas esrd-rel ventur
preced set healthcar partner
acquisit total cash stock consider
billion net cash acquir subsequ
divestitur price billion net cash
held somewhat comfort firm
manag team -- led new ceo veteran
previou leader kidney divis javier
rodriguez -- note prefer tuck-in acquisit
suspect futur acquisit focu acquir
dialysi clinic global adjac vertic
term size manag indic consid
deal would like peak hundr million dollar
rang rather multibillion-dollar rang think
smaller deal like would easier integr
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
manag
see posit indic investor keep
mind first largest sharehold
stake compani file made april warren
buffett berkshir hathaway penchant
invest firm sustain competit advantag
would also note uneven play field
term financi interest vote power
posit comparison versu freseniu medic
support minor investor second think
share repurchas activ past year
attract price benefit long-term
sharehold final think compens structur
place compani board hold
manag account sharehold valu creation
manag annual bonu tie oper
incom bonu clinic outcom
strateg object think critic
measur
incent pay execut offic made equiti versu
cash prior split perform share
performance-bas share relat adjust
earn relat sharehold return metric
time-bas vest schedul said like
see insid ownership upper level
manag particularli given member long tenur
firm whole director offic group hold less
equiti stake
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
dialysi dynamo davita freseniu medic
narrow moat appear fairli valu
publish fresh take domin dialysi
servic compani freseniu medic
review result slight cut fair
valu estim view compani
fairli valu also reiter narrow moat
stabl trend rate organ
intang asset
compani oper similar scale
concentr dialysi industri cumul
treat patient respect
servic busi account half freseniu
nearli profit think enjoy similar
long-term competit advantag primari moat
sourc
advantag term intang asset
built similarli larg network dialysi clinic
lead clinic count slightli
freseniu larger global strong reput
high-qual servic extens physician relationship
conveni locat influenc lifeblood
busi -- referr nephrologist beyond
intang asset think scale-rel factor lead cost
advantag negoti power versu key payer
help earn econom profit
gener see stabl dynam moat trend
well primarili think would difficult
new competitor enter destabil market
home-rel option becom viabl
choic end patient current around patient
global could rise intermedi term
firm abl particip trend
crucial role clinic play train
monitor home patient well typic care
journey includ in-clin servic dialysi
see firm close fair valu
new fair valu estim per share
slightli new fair valu estim
repres earn multipl time
compound annual next five
year heavili weight toward share repurchas
on-going cash flow proce recent
took deeper cut freseniu medic fair
valu estim stand per adr
still moder recent share price
reduct reflect fresh look organ
primarili on-going
invest boost at-hom
treatment initi expect pay
eventu think invest littl
higher previous model new estim valu
freseniu around time expect earn
expect compound annual ep growth
includ share repurchas although lighter
also note investor continu monitor
polici landscap signific chang importantli
think medicar requir elimin
privat insur industri would repres larg
neg catalyst industri enact
without signific medicar rate chang dialysi
compani depend commerci
insur patient virtual servic profit
patient convert medicare-level
reimburs rate without rate adjust believ
compani return could drop capit cost
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
similar firm revenu growth compani cost
control effort share repurchas led strong rise
per share grew consensu
particular pleas see continu share
repurchas discount price reduc
firm share count sinc dmg sale close
june quarter repurchas billion
share averag share price per share
discount fair valu estim
strong underli result abl
increas outlook davita
expect least million adjust oper
profit new rang billion
increas cash flow expect includ higher
oper cash flow rang billion
billion previous reduc capit
expenditur expect new rang million-
million million previous
expect earn per
share new rang primarili
reduc share count expect off-set somewhat cost
relat ballot initi
current
fortun poll suggest half
popul support medicar scenario
believ scenario repres low-prob
less risk within forecast period
major posit senat new presid
left wing democrat parti republican voter
remain significantli oppos plan next
year view scenario privat insur provid
medic pharmaceut benefit employ
even govern program much like
extrem medicar scenario privat
insur industri longer exist poll show
ad public option current healthcar system
support two third potenti voter
support even republican reflect
view well like scenario suspect
freseniu abl keep gener
solid profit respect dialysi servic
busi import econom
repurchas help davita consensu boost
narrow-moat turn strong third-quart result
consensu estim capit iq led
firm boost outlook share rise
after-hour trade still view moder
under-valued rel fair valu estim overal
view quarter result favor
organ pressur regulatori
concern year
first quarter sell davita medic group
dmg turn billion sale growth
year year slightli consensu billion
normal organ patient volum growth
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
